Novartis Investigative Site
Abilene, Texas 79606
We've found
1 trials
at this facility
Age-Related Macular Degeneration Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
